Similar results have been previously obtained in Cx43 and Cx45 expression during endotoxemia and treatment with boldine that rapidly blocked Cxs and completely abrogated Cx45 and Cx43 immunoreactivity [36]. The gene discussed is GJA1; the disease is serum lipopolysaccharide activity.